• Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

Treat GERD-Associated Heartburn With Acid Suppressants


Proton pump inhibitors in GERD-associated heartburn are indicated to heal mucosal damage (erosive esophagitis).

Which of the following symptoms associated with GERD is most likely to respond to acid suppressants?

A. Regurgitation
B. Heartburn
C. Cough
D. Globus

Answer: B 

The objectives of acid suppressant therapy, such as proton pump inhibitors (PPIs), in the management of GERD are to heal any mucosal damage (erosive esophagitis) and help control symptoms. Most patients have nonerosive reflux disease and the primary goal of treatment is symptom control. The two cardinal symptoms of GERD are heartburn and regurgitation. Atypical symptoms include cough, hoarseness, globus, chest pain, and halitosis. The symptom most likely to respond to PPIs is heartburn. Because PPIs do not alter lower esophageal sphincter function, patients may continue to experience regurgitation, since PPIs will reduce acidity but not the number of reflux episodes. Response of atypical symptoms is generally lower than that of typical symptoms.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.